The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance
Open accessAbstract
To test the hypothesis that obesity/insulin resistance impairs both endothelium-dependent vasodilation and insulin-mediated augmentation of endothelium-dependent vasodilation, we studied leg blood flow (LBF) responses to graded intrafemoral artery infusions of methacholine chloride (MCh) or sodium nitroprusside (SNP) during saline infusion and euglycemic hyperinsulinemia in lean insulin-sensitive controls (C), in obese insulin-resistant subjects (OB), and in subjects with non-insulin-dependent diabetes mellitus (NIDDM). MCh induced increments in LBF were approximately 40% and 55% lower in OB and NIDDM, respectively, as compared with C (P < 0.05). Euglycemic hyperinsulinemia augmented the LBF response to MCh by - 50% in C (P < 0.05 vs saline) but not in OB and NIDDM. SNP caused comparable increments in LBF in all groups. Regression analysis revealed a significant inverse correlation between the maximal LBF change in response to MCh and body fat content. Thus, obesity/insulin resistance is associated with (a) blunted endothelium-dependent, but normal endothelium-independent vasodilation and (b) failure of euglycemic hyperinsulinemia to augment endothelium-dependent vasodilation. Therefore, obese/insulin-resistant subjects are characterized by endothelial dysfunction and endothelial resistance to insulin's effect on enhancement of endothelium-dependent vasodilation. This endothelial dysfunction could contribute to the increased risk of atherosclerosis in obese insulin-resistant subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, IR per se has a direct impact on endothelial function, distinct from effects related to unfavorable changes in lipid composition or blood pressure (9).”
From Improved Endothelial Function With Metformin in Type 2 Diabetes Mellitus (2001) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Kumar, M. V. J., & Chippada, A. R. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
Panza, J. A., Quyyumi, A. A., Brush, J. E., & Epstein, S. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230105 · Cited by 2,366
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
Vallance, P., Collier, J., & Moncada, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91013-1 · Cited by 1,590
Steinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N. S., & Baron, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117433 · Cited by 1,216
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11367.x · Cited by 1,158
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,117
Flagged first, then by citations
Research works printed but not linked: 1
- Brozek, J., and A. Henschel. 1961. Techniques for measuring body com- position: proceedings of a conference. In Conference on Techniques for Mea- suring Body Composition. National Academy of Sciences, National Research Council. Washington DC. 78-89.
Cited by
Sorted by citations
Items 101–200 of 1,001
Microvascular Function Relates to Insulin Sensitivity and Blood Pressure in Normal Subjects
Serné, E. H., Stehouwer, C. D. A., ter Maaten, J. C., ter Wee, P. M., Rauwerda, H., Donker, A. J. M., & Gans, R. O. B. (1999) · Circulation · doi:10.1161/01.cir.99.7.896 · Cited by 265
Pierce, G. L., Lesniewski, L. A., Lawson, B. R., Beske, S. D., & Seals, D. R. (2009) · Circulation · doi:10.1161/circulationaha.108.804294 · Cited by 262
Insulin-induced vasodilatation: physiology or pharmacology?
Yki‐Järvinen, H., & Utriainen, T. (1998) · Diabetologia · doi:10.1007/s001250050919 · Cited by 261
“In other conditions, such as obesity [ 48 ], hypertension [62, 63], IDDM [67, 101] and NIDDM (see [102] for review), endothelial dysfunction and insulin resistance frequently coexist.”
BackgroundInfluentialObesity and cardiovascular disease
Poirier, P., & Eckel, R. H. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0049-8 · Cited by 259
“This hypercoagulable state, which accompanies excessive central fat deposition, may also be associated with impaired endothelial function [ 23 ,24].”
BackgroundHyperinsulinemia: An Early Indicator of Metabolic Dysfunction
Thomas, D. D., Corkey, B. E., Istfan, N. W., & Apovian, C. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00065 · Cited by 284
“Subjects with obesity had diminished endothelium-dependent vasodilation compared with lean controls during a hyperinsulinemic-euglycemic clamp [158].”
BackgroundAltered Vascular Function in Young Women with Polycystic Ovary Syndrome
Kelly, C. J., Speirs, A., Gould, G. W., Petrie, J. R., Lyall, H., & Connell, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8199 · Cited by 261
Cardioprotection by Adiponectin
Ouchi, N., Shibata, R., & Walsh, K. X. (2006) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.03.001 · Cited by 260
“Collectively, these findings suggest that down-regulation of the adiponectin–AMPK regulatory pathway may participate in endothelial cell dysfunction and vessel rarefaction that are observed in obese states (Al Suwaidi et al. 2001, Lind and Lithell 1993, Steinberg et al. 1996, Yilmaz et al. 2003).”
BackgroundA Novel Pathway to the Manifestations of Metabolic Syndrome
Sonnenberg, G. E., Krakower, G. R., & Kissebah, A. H. (2004) · Obesity Research · doi:10.1038/oby.2004.24 · Cited by 263
Suwaidi, J. M. S. A., Higano, S. T., Holmes, D. R., Lennon, R. J., & Lerman, A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01212-8 · Cited by 259
“Another possibility for this differential effect at the resistance vessels may be related to the coexistence of insulin resistance syndrome, which is associated with obesity, in our patients (26).”
BackgroundEndothelial dysfunction in obesity
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_15 · Cited by 255
Vascular Inflammation in Obesity and Sleep Apnea
Jelić, S., Lederer, D. J., Adams, T., Padeletti, M., Colombo, P. C., Factor, P. H., & Jemtel, T. H. L. (2010) · Circulation · doi:10.1161/circulationaha.109.900357 · Cited by 255
“cessation of exposure to hypoxia.(6,7) Repetitive hypoxia and arousals occur immediately after discontinuation of CPAP therapy in patients with OSA.”
BackgroundAgatisa, P. K., Ness, R. B., Roberts, J. M., Costantino, J. P., Kuller, L. H., & McLaughlin, M. K. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00298.2003 · Cited by 254
“Obesity and concomitant abnormal maternal lipid metabolism (17) and insulin resistance (32) may have some bearing on the attenuated endothelial-dependent blood flow response observed in the preeclamptic study participants.”
BackgroundMolecular, cellular and functional imaging of atherothrombosis
Choudhury, R. P., Fuster, V., & Fayad, Z. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1548 · Cited by 252
Schindler, T. H., Cardenas, J., Prior, J. O., Facta, A. D., Kreissl, M. C., Zhang, X.-L., Sayre, J. W., Dahlbom, M. L., Licinio, J., & Schelbert, H. R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.062 · Cited by 253
“Previous studies have reported an association between besity and endothelial dysfunction of the peripheral circuation (5,6).”
BackgroundCleland, S. J., Sattar, N. A., Petrie, J. R., Forouhi, N. G., Elliott, H. L., & Connell, J. (2000) · Clinical Science · doi:10.1042/cs0980531 · Cited by 250
Brook, R. D., Bard, R. L., Rubenfire, M., Ridker, P. M., & Rajagopalan, S. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02088-4 · Cited by 246
Shinozaki, K., Nishio, Y., Okamura, T., Yoshida, Y., Maegawa, H., Kojima, H., Masada, M., Toda, N., Kikkawa, R., & Kashiwagi, A. (2000) · Circulation Research · doi:10.1161/01.res.87.7.566 · Cited by 242
Bao, D. Q., Mori, T. A., Burke, V., Puddey, I. B., & Beilin, L. J. (1998) · Hypertension · doi:10.1161/01.hyp.32.4.710 · Cited by 237
Patel, T. P., Rawal, K., Bagchi, A. K., Akolkar, G., Bernardes, N., Dias, D. D. S., Gupta, S. S., & Singal, P. K. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9515-6 · Cited by 243
“Also, this defect was a consequence of impaired insulin action, as it was not observed in the basal state suggesting that IR extends to large conduit vessels as well as to vessels regulating peripheral blood flow thereby increasing the risk toward cardiovascular diseases [60, 67, 68].”
BackgroundWilliams, I. L., Wheatcroft, S. B., Shah, A. M., & Kearney, M. T. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801995 · Cited by 265
Zimmet, P., Boyko, E. J., Collier, G. R., & de Courten, M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07783.x · Cited by 234
Evaluation of the microcirculation in vascular disease
Abularrage, C. J., Sidawy, A. N., Aidinian, G., Singh, N. N., Weiswasser, J. M., & Arora, S. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.05.019 · Cited by 233
Insulin resistance and the endothelium
Hsueh, W. A., Lyon, C. J., & Quiñones, M. J. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.042 · Cited by 236
Diamanti‐Kandarakis, E., Spina, G., Kouli, C., & Migdalis, I. N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7904 · Cited by 229
Pistrosch, F., Passauer, J., Fischer, S., Fuecker, K., Hanefeld, M., & Gross, P. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.484 · Cited by 225
“These results imply that endothelial insulin resistance may be an aspect of insulin resistance in general (20).”
BackgroundDietary fat, fatty acid composition in plasma and the metabolic syndrome
Vessby, B. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200302000-00004 · Cited by 291
Defective Mitochondrial Biogenesis
Nisoli, E., Clementi, E., Carruba, M. O., & Moncada, S. (2007) · Circulation Research · doi:10.1161/01.res.0000259591.97107.6c · Cited by 229
Cellular and molecular mechanisms of endothelial dysfunction in diabetes
Roberts, A., & Porter, K. E. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113500680 · Cited by 234
Cardiovascular Function in Acromegaly
Clayton, R. N. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0009 · Cited by 223
Obesity, pregnancy, inflammation, and vascular function
Denison, F. C., Roberts, K. A., Barr, S. M., & Norman, J. E. (2010) · Reproduction · doi:10.1530/rep-10-0074 · Cited by 221
“At a functional level, the vasodilatory response to endothelium-dependent vasodilators such as acetylcholine is attenuated (Steinberg et al. 1996), whereas the response to endothelium-independent vasodilators, such as sodium nitroprusside, remains intact (Van Guilder et al.”
Obesity and vascular dysfunction
Stapleton, P. A., James, M. E., Goodwill, A. G., & Frisbee, J. C. (2008) · Pathophysiology · doi:10.1016/j.pathophys.2008.04.007 · Cited by 221
“Patients with metabolic syndrome also show blunted endothelium-dependent dilation responses to infused vasodilators, relative to control patients, while endotheliumindependent mechanisms remained intact [62].”
BackgroundAn Integrated View of Insulin Resistance and Endothelial Dysfunction
Muniyappa, R., Iantorno, M., & Quon, M. J. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.001 · Cited by 227
Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men
Lakka, T. A., Lakka, H., Salonen, R., Kaplan, G. A., & Salonen, J. T. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00514-1 · Cited by 218
Insulin Resistance the Hinge Between Hypertension and Type 2 Diabetes
Mancusi, C., Izzo, R., Gioia, G. D., Losi, M. A., Barbato, E., & Morisco, C. (2020) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-020-00408-8 · Cited by 232
Srinivasan, S. R., Hatley, M., Bolick, D. T., Palmer, L. A., Edelstein, D., Brownlee, M., & Hedrick, C. C. (2004) · Diabetologia · doi:10.1007/s00125-004-1525-1 · Cited by 216
“Several studies have demonstrated impaired endothelium-dependent vasorelaxation in diabetic humans [3, 4] and in experimental diabetic animals [5, 6].”
BackgroundObesity and Atherosclerosis: Mechanistic Insights
Lovren, F., Teoh, H., & Verma, S. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.11.031 · Cited by 219
Michele, M. D., Panico, S., Iannuzzi, A., Celentano, E., Ciardullo, A. V., Galasso, R., Sacchetti, L., Zarrilli, F., Bond, M. G., & Rubba, P. (2002) · Stroke · doi:10.1161/01.str.0000038989.90931.be · Cited by 214
Effects of exercise training on vascular function in obese children
Watts, K., Beye, P., Siafarikas, A., O’Driscoll, G., Jones, T. W., Davis, E. A., & GREEN, D. J. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.02.027 · Cited by 211
The sweeter side of ACE2: Physiological evidence for a role in diabetes
Bindom, S. M., & Lazartigues, E. D. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.020 · Cited by 216
Lambert, E., Sari, C. I., Dawood, T., Nguyen, J., McGrane, M., Eikelis, N., Chopra, R., Wong, C., Chatzivlastou, K., Head, G., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.155663 · Cited by 209
Endothelial Function in HIV-Infected Persons
Solages, A., Vita, J. A., Thornton, D. J., Murray, J. E., Heeren, T., Craven, D. E., & Horsburgh, C. R. (2006) · Clinical Infectious Diseases · doi:10.1086/503261 · Cited by 209
“Based on current published literature on endothelial dysfunction [31-33] age, BMI, smoking, total cholesterol, fasting blood sugar and gender were included in the model.”
BackgroundZhou, M.-S., Schulman, I. H., & Zeng, Q. (2012) · Vascular Medicine · doi:10.1177/1358863x12450094 · Cited by 214
Metabolic syndrome as a risk factor for neurological disorders
Farooqui, A. A., Farooqui, T., Panza, F., & Frisardi, V. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0840-1 · Cited by 213
“However, several pathways involving endothelial dysfunction [15], arterial stiffness [16] and inflammation may contribute to hypertension [17].”
BackgroundThe role of perivascular adipose tissue in obesity‐induced vascular dysfunction
Xia, N., & Li, H. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13650 · Cited by 206
Endothelial Dysfunction Is Associated With Cholesterol Levels in the High Normal Range in Humans
Steinberg, H. O., Bayazeed, B., Brechtel, G., Johnson, A., Cronin, J., & Baron, A. (1997) · Circulation · doi:10.1161/01.cir.96.10.3287 · Cited by 206
Endothelial dysfunction in insulin resistance and type 2 diabetes
Jansson, P. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01830.x · Cited by 203
Vázquez, L. A., Pazos, F., de Berrazueta, J. R., Fernández-Escalante, C., García‐Unzueta, M. T., Freijanes, J., & Amado, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032059 · Cited by 205
“However, reports assessing in vivo vascular reactivity in humans demonstrated that the endothelium-dependent vasodilatory response was altered in experimental mild hyperinsulinemic subjects (10) and in obese individuals who displayed IR (11, 12).”
BackgroundDesouza, C. V., Parulkar, A., Lumpkin, D., Akers, D. L., & Fonseca, V. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1336 · Cited by 204
Rallidis, L. S., Lekakis, J. P., Kolomvotsou, A., Zampelas, A., Vamvakou, G. D., Efstathiou, S. P., Dimitriadis, G., Raptis, S., & Kremastinos, D. T. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27290 · Cited by 201
Diet-induced insulin resistance precedes other aspects of the metabolic syndrome
Barnard, R. J., Roberts, C. K., Varon, S. M., & Berger, J. J. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.84.4.1311 · Cited by 201
“Furthermore, it recently has been demonstrated that insulin-resistant individuals demonstrate endothelial dysfunction (44).”
BackgroundThe Relationship between Hyperinsulinemia, Hypertension and Progressive Renal Disease
El-Atat, F. A., Stas, S. N., McFarlane, S. I., & Sowers, J. R. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133698.80390.37 · Cited by 203
“K/AKT signaling pathways, and AngII inhibits this vasorelaxant effect of insulin/IGF-1 (7,9,12).”
BackgroundRetinol Binding Protein-4 Levels and Clinical Features of Type 2 Diabetes Patients
Takebayashi, K., Suetsugu, M., Wakabayashi, S., Aso, Y., & Inukai, T. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1249 · Cited by 198
Raitakari, M., Ilvonen, T., Ahotupa, M., Lehtimäki, T., Harmoinen, A., Suominen, P., Elo, J., Hartiala, J., & Raitakari, O. T. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000109749.11042.7c · Cited by 198
Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress
Galili, O., Versari, D., Sattler, K., Olson, M. L., Mannheim, D., McConnell, J. P., Chade, A., Lerman, L. O., & Lerman, A. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00628.2006 · Cited by 198
“The fundamental feature in the pathogenesis of the metabolic syndrome is considered insulin resistance (10, 38); in addition, endothelial dysfunction, an early manifestation of atherosclerosis and an independent predictor of cardiovascular events (20, 30, 52, 53), has also been consistently associated with the metabol…”
BackgroundShinozaki, K., Ayajiki, K., Nishio, Y., Sugaya, T., Kashiwagi, A., & Okamura, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000111136.86976.26 · Cited by 198
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus
Scheen, A. J. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70147-7 · Cited by 199
“It has been shown that the ACEI quinapril may significantly improve vascular sensitivity to insulin via global enhancement of endothelial function [26], and endothelial dysfunction is associated with obesity, insulin resistance, hypertension and type 2 diabetes [27, 28].”
BackgroundMetabolic effects of smoking cessation
Harris, K. K., Zopey, M., & Friedman, T. C. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.32 · Cited by 195
Brocq, M. L. L., Leslie, S. J., Milliken, P. H., & Megson, I. L. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.2013 · Cited by 196
“Clinically, endothelial dysfunction is associated with insulin resistance (179, 214, 281, 378, 395) (Fig.”
Brouwers, O., Niessen, P., Haenen, G. R. M. M., Miyata, T., Brownlee, M., Stehouwer, C. D. A., Mey, J. G. R. D., & Schalkwijk, C. (2010) · Diabetologia · doi:10.1007/s00125-010-1677-0 · Cited by 198
“Several studies have demonstrated impaired endothelium-dependent vasorelaxation in diabetic patients [2, 3] and in animal models of diabetes [4, 5].”
Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
Chaturvedi, N., Bandinelli, S., Mangili, R., Penno, G., Rottiers, R. E., & Fuller, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00789.x · Cited by 191
Endothelial Dysfunction, Obesity and Insulin Resistance
Prieto, D., Contreras, C., & Sánchez, A. (2014) · Current Vascular Pharmacology · doi:10.2174/1570161112666140423221008 · Cited by 191
Mechanisms of endothelial dysfunction in obesity.
Avogaro, A., & de Kreutzenberg, S. V. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.04.020 · Cited by 188
Endothelium-derived relaxing factors: A focus on endothelium-derived hyperpolarizing factor(s)
McGuire, J. J., Ding, H., & Triggle, C. R. (2001) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-79-6-443 · Cited by 188
Clark, M. G. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90477.2008 · Cited by 195
“In general, obese subjects show impaired responses in skin and resistance arteries to classic endothelium-dependent vasodilators (34, 38, 168), and this may extend to impaired capillary recruitment in response to reactive hyperemia (2, 34, 38, 56) as well as shear stress (2).”
BackgroundChinen, I., Shimabukuro, M., Yamakawa, K., Higa, N., Matsuzaki, T., Noguchi, K., Ueda, S., Sakanashi, M., & Takasu, N. (2006) · Endocrinology · doi:10.1210/en.2006-1132 · Cited by 195
Microvascular endothelial dysfunction in rheumatoid arthritis
Bordy, R., Totoson, P., Prati, C., Marie, C., Wendling, D., & Demougeot, C. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0022-8 · Cited by 189
Hemostatic Markers of Endothelial Dysfunction and Risk of Incident Type 2 Diabetes
Meigs, J. B., O’Donnell, C. J., Tofler, G. H., Benjamin, E. J., Fox, C. S., Lipinska, I., Nathan, D. M., SULLIVAN, L. M., D’Agostino, R. B., & Wilson, P. W. F. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-1041 · Cited by 184
Ding, Y., Vaziri, N. D., Coulson, R., Kamanna, V. S., & Roh, D. D. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.1.e11 · Cited by 184
“Several studies have demonstrated impaired endothelium-dependent vasorelaxation in diabetic humans (18, 33, 41, 54, 58) and experimental animals (4, 15, 43, 49).”
BackgroundNaderali, E. K., Ratcliffe, S. H., & Dale, M. C. (2009) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317509348208 · Cited by 187
Overweight, physical activity and high blood pressure in children: a review of the literature.
Torrance, B. D., McGuire, K. A., Lewanczuk, R. Z., & McGavock, J. (2007) · PubMed · Cited by 182
Cheng, X., Siow, R. C. M., & Mann, G. E. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3283 · Cited by 182
Diabetes, the Metabolic Syndrome, and Ischemic Stroke
Air, E. L., & D, B. M. K. M. (2007) · Diabetes Care · doi:10.2337/dc06-1537 · Cited by 180
Vascular Effects of Improving Metabolic Control With Metformin or Rosiglitazone in Type 2 Diabetes
Natali, A., Baldeweg, S. E., Toschi, E., Capaldo, B., Barbaro, D., Gastaldelli, A., Yudkin, J. S., & Ferrannini, E. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1349 · Cited by 180
“In these subjects, the vascular defect usually clusters with features of the metabolic syndrome (visceral obesity [10], hypertension [11], and abundance of small, dense LDL cholesterol particles [8]).”
BackgroundThe impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation
Hashimoto, M., Akishita, M., Eto, M., Kozaki, K., Ako, J., Sugimoto, N., YOSHIZUMI, M., Toba, K., & Ouchi, Y. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800620 · Cited by 183
Sonta, T., Inoguchi, T., Tsubouchi, H., Sekiguchi, N., Kobayashi, K., Matsumoto, S., Utsumi, H., & Nawata, H. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.001 · Cited by 180
Effect of Endothelium-Specific Insulin Resistance on Endothelial Function In Vivo
Duncan, E. R., Crossey, P. A., Walker, S., Anilkumar, N. P., Poston, L., Douglas, G., Ezzat, V., Wheatcroft, S. B., Shah, A. M., & Kearney, M. T. (2008) · Diabetes · doi:10.2337/db07-1111 · Cited by 188
“Insulin resistance is associated with endothelial dysfunction (11), and this may account at least in part for its ultimately deleterious consequences.”
BackgroundChen, H., Karne, R. J., Hall, G., Campia, U., Panza, J. A., Cannon, R. O., Wang, Y., Katz, A., Levine, M., & Quon, M. J. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00768.2005 · Cited by 178
Renin-Angiotensin System and Angiotensin Receptor Blockers in the Metabolic Syndrome
Prasad, A., & Quyyumi, A. A. (2004) · Circulation · doi:10.1161/01.cir.0000141736.76561.78 · Cited by 176
Tack, C. J. J., Ong, M. K. E., Lutterman, J. A., & Smits, P. (1998) · Diabetologia · doi:10.1007/s001250050948 · Cited by 177
“Recent reports indeed claim a reduced vasodilator response to metacholine and not to sodium nitroprusside in insulin resistant obese individuals indicating a specific defect in endothelial-dependent vasodilatation [13].”
BackgroundRask‐Madsen, C., Domínguez, H., Ihlemann, N., Hermann, T. S., Køber, L., & Torp-Pedersen, C. T. (2003) · Circulation · doi:10.1161/01.cir.0000091406.72832.11 · Cited by 180
Youd, J. M., Rattigan, S., & Clark, M. G. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1904 · Cited by 180
Endothelial dysfunction in metabolic syndrome: Prevalence, pathogenesis and management
Τζιόμαλος, Κ., Athyros, V. G., Karagiannis, A. I., & Mikhailidis, D. P. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.08.006 · Cited by 177
“in most studies [46,57] but not in all [24,29].”
BackgroundThe Metabolic Syndrome and Cardiovascular Risk in Cushing's Syndrome
Pivonello, R., Faggiano, A., Lombardi, G., & Colao, A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.010 · Cited by 173
“Impaired vasodilation after acetylcholine or hyperemia [39], enhanced large artery stiffness [40], and increased thrombotic diatesis [41] have been demonstrated in all states associated with metabolic syndrome/ insulin resistance development, such as obesity [42], impairment of glucose tolerance [43], diabetes mellitu…”
BackgroundO’Driscoll, G., GREEN, D. J., Maiorana, A., Stanton, K. G., Colreavy, F. B., & Taylor, R. R. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00065-0 · Cited by 174
Long-term Pharmacotherapy of Obesity 2000
Glazer, G. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.15.1814 · Cited by 167
The insulin resistance syndrome: physiological considerations
Kashyap, S. R., & DeFronzo, R. A. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.001 · Cited by 178
Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature
Barrett, E. J., Wang, H., Upchurch, C. T., & Liu, Z. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00186.2011 · Cited by 175
Apelin Decreases Lipolysis via Gq, Gi, and AMPK-Dependent Mechanisms
Yue, P., Jin, H. H., Xu, S., Aillaud, M., Deng, A. C., Azuma, J., Kundu, R. K., Reaven, G. M., Quertermous, T., & Tsao, P. S. (2010) · Endocrinology · doi:10.1210/en.2010-0576 · Cited by 171
“that circulating FFA levels (13, 34) as well as basal rates of”
BackgroundSzabó, C., Zanchi, A., Komjáti, K., Pacher, P., Królewski, A. S., Quist, W. C., LoGerfo, F. W., Horton, E. S., & Veves, A. (2002) · Circulation · doi:10.1161/01.cir.0000038365.78031.9c · Cited by 171
Retinal Vessel Diameters and Obesity: A Population‐Based Study in Older Persons
Wang, J. J., Taylor, B., Wong, T. Y., Chua, B., Rochtchina, E., Klein, R., & Mitchell, P. (2006) · Obesity · doi:10.1038/oby.2006.27 · Cited by 171
“Although a sedentary lifestyle and poor dietary habits play a predominant role in development of obesity, other predisposing factors have been hypothesized and investigated (11,12).”
BackgroundObesity, inflammation and endothelial dysfunction.
Iantorno, M., Campia, U., Daniele, N. D., Nisticò, S. P., Forleo, G., Cardillo, C., & Tesauro, M. (2014) · PubMed · Cited by 169
Moderate Regular Exercise Increases Basal Production of Nitric Oxide in Elderly Women
Maeda, S., Tanabe, T., Otsuki, T., Sugawara, J., Iemitsu, M., Miyauchi, T., Kuno, S., Ajisaka, R., & Matsuda, M. (2004) · Hypertension Research · doi:10.1291/hypres.27.947 · Cited by 168
“It has been reported that insulin-resistant humans have impaired endothelium-dependent vasodilator responses (48).”
BackgroundCurrent concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome
Reusch, J. E. B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02555-9 · Cited by 167
Inflammatory and endothelial markers in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Alexandraki, K., Piperi, C., Protogerou, A. D., Katsikis, I., Paterakis, T., Lekakis, J., & Panidis, D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01712.x · Cited by 168
Nontraditional Risk Factors for Cardiovascular Disease in Diabetes
Fonseca, V. A., Desouza, C. V., Asnani, S., & Jialal, I. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0034 · Cited by 169
Pierce, G. L., Beske, S. D., Lawson, B. R., Southall, K. L., Benay, F. J., Donato, A. J., & Seals, D. R. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.111427 · Cited by 169
The atherogenic lipoprotein phenotype and vascular endothelial dysfunction
Sattar, N. A., Petrie, J. R., & Jaap, A. J. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00037-9 · Cited by 162
Montero, D., Walther, G., Pérez‐Martin, A., Roche, E., & Vinet, A. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00956.x · Cited by 166
“Although both endothelial dysfunction and IR are present in obese adults (32,62,63), their coexistence and relationship have not been clearly demonstrated so far in obese children (58).”
BackgroundVirdis, A., Duranti, E., Rossi, C., Dell’Agnello, U., Santini, E., Anselmino, M., Chiarugi, M., Taddei, S., & Solini, A. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu072 · Cited by 169
The Role of Aldosterone in Obesity-Related Hypertension
Kawarazaki, W., & Fujita, T. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw003 · Cited by 170
Metadata
- Authors
- Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D.
- Affiliations
- Indiana University (US)
- Richard L. Roudebush VA Medical Center (US)
- Indiana University Hospital (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1996-06-01
- Volume
- 97
- Issue
- 11
- Pages
- 2601-2610
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507347
- OpenAlex
- W1982811953
- Cited by
- 1,687
- References
- 59
- Citations by year
- 2026: 11 · 2025: 23 · 2024: 17 · 2023: 30 · 2022: 19 · 2021: 32 · 2020: 30 · 2019: 36 · 2018: 36 · 2017: 46 · 2016: 50 · 2015: 51 · 2014: 69 · 2013: 69 · 2012: 61
- FWCI
- 18.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- American Heart Association
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK42469, P60DK020542, DK20542)
- National Center for Research Resources (M 01-RR750-19)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- obesity, insulin resistance, endothelial dysfunction, endothelium-dependent vasodilation, euglycemic hyperinsulinemia, leg blood flow, methacholine, sodium nitroprusside, type 2 diabetes, fat mass, atherosclerosis risk
- MeSH terms
- Adult, Blood Glucose, Blood Pressure, Cholesterol, Diabetes Mellitus, Type 2, Endothelium, Vascular, Fatty Acids, Nonesterified, Glucose, Humans, Hyperinsulinism, Infusions, Intra-Arterial, Infusions, Intravenous, Insulin, Insulin Resistance, Leg, Cholesterol, HDL, Cholesterol, LDL, Nitroprusside, Obesity, Reference Values, Regional Blood Flow, Syndrome, Time Factors, Triglycerides, Vasodilation, Glucose Clamp Technique, Body Mass Index, Methacholine Chloride
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
